*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Platinum-based antineoplastic agents are critical chemotherapy drugs. <strong>Carboplatin</strong> (CAS 41575-94-4, C6H12N2O4Pt), <strong>Cisplatin</strong> (CAS 15663-27-1, Cl2H2N2Pt), and <strong>Oxaliplatin</strong> (CAS 61825-94-3, C8H14N2O4Pt) are synthesized via platinum salt reactions. These compounds function by forming DNA cross-links to inhibit tumor cell replication.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Bulk production of injectable formulations for solid tumors.</li>
<li><strong>Pharmaceutical R&D:</strong> Active Pharmaceutical Ingredients (APIs) for clinical trials.</li>
<li><strong>Hospital Supply Chains:</strong> Distribution to oncology centers for intravenous administration.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly handle in controlled environments due to nephrotoxicity and neurotoxicity risks. Store under inert atmosphere at controlled temperatures. Personnel must utilize full PPE to prevent dermal absorption and inhalation exposure.</p>